The effects on rat thyroid function of an hepatic microsomal enzyme inducer

Area of Science:

• Pharmacology
• Toxicology
• Endocrinology

Background:

• Drug metabolism studies often involve evaluating the effects of xenobiotics on enzyme systems.
• The hypothalamic-pituitary-thyroid (HPT) axis is sensitive to various endogenous and exogenous factors.
• Understanding how compounds like beta-naphthoflavone and phenobarbitone interact with these systems is crucial.

Purpose of the Study:

• To investigate the effects of beta-naphthoflavone and phenobarbitone on P450-related enzyme activities.
• To assess the impact of these compounds on thyroid hormone levels (T4, T3) and thyroid-stimulating hormone (TSH).
• To examine the resulting changes in thyroid and liver weights and histopathology.

Main Methods:

• Male albino rats were administered beta-naphthoflavone (25 and 60 mg/kg) or phenobarbitone (100 mg/kg) daily for two weeks.
• P450-related enzyme activities and p-nitrophenol glucuronidation were measured.
• Plasma concentrations of T4, T3, and TSH were determined at various time points.
• Thyroid and liver weights were recorded, and histopathological examinations were performed.

Main Results:

• Both compounds induced P450 enzyme activities; beta-naphthoflavone showed a greater induction of p-nitrophenol glucuronidation.
• Beta-naphthoflavone significantly reduced T4 and T3 levels, while phenobarbitone only affected T3.
• Both agents increased thyroid and liver weights, with observed thyroid follicular epithelial hypertrophy.

Conclusions:

• The observed early changes in thyroid hormones are likely due to enhanced hepatic clearance via induced thyroxine glucuronidation.
• Thyroid hypertrophy suggests an activation of the HPT axis in response to these xenobiotics.
• These findings highlight the complex interplay between drug metabolism and endocrine function.